# OnCo record paper-beamion-lung-1-zongertinib-nejm-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-beamion-lung-1-zongertinib-nejm-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-beamion-lung-1-zongertinib-nejm-2025" ;
  schema:name "Beamion LUNG-1: zongertinib in previously treated HER2-mutant non-small-cell lung cancer"@en ;
  schema:description "The oral HER2-selective kinase inhibitor zongertinib shrank tumours in about seven in ten patients with previously treated HER2-mutant lung cancer with little of the diarrhoea and rash that plagued earlier HER2 pills, becoming the first oral drug approved for this driver."@en ;
  schema:url <https://onco.cc/key-papers/paper-beamion-lung-1-zongertinib-nejm-2025/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2503704>, <https://pubmed.ncbi.nlm.nih.gov/40293180/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2503704> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Heymach JV, Ruiter G, Ahn MJ, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/zongertinib/> ;
  onco:trials <https://onco.cc/trials/beamion-lung-1/> ;
  onco:journals <https://onco.cc/journals/nejm/> .